Clinical Trial Update: How Long Should we Give Steroids for Patients With Severe PCP [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from McGill University Health Centre is investigating the optimal duration of steroid therapy for severe Pneumocystis pneumonia; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Jirovecii Pneumonia
• Pneumocystis Pneumonia

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Pneumocystis Pneumonia, Pneumocystis | Phase 4 | Status: NOT_YET_RECRUITING